Cardiovascular disease, estrogen deficiency, and inflammatory cytokines

Hypertension

Volumn 48, Issue 3, 2006, Pages 372-373

  Reckelhoff, Jane F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CANDESARTAN; CONJUGATED ESTROGEN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; ESTROGEN; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MEDROXYPROGESTERONE ACETATE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROSTACYCLIN DERIVATIVE; SUPEROXIDE; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; ESTROGEN DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MENOPAUSE; NOTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; CARDIOVASCULAR DISEASES; CYTOKINES; ESTROGENS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; POSTMENOPAUSE;

EID: 33747443879     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000235866.97871.9d     Document Type: Note

References (11)

1. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004;43:918-923.
2. Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Tumor-necrosis factor-alpha and vascular angiotensin II in estrogen-deficient rats. Hypertension. 2006;48:497-503.
3. Weiner CP, Lizasain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium dependent NO synthase by sex hormones. Proc Natl Acad Sci U S A. 1994;91:5212-5216.
4. Wassmann S, Nickenig G. Pathophysiological regulation of the AT1 receptor and implications for vascular disease. J Hypertens. 2006;24(suppl):S15-S21.
5. Browatzki M, Larsen D, Pfeiffer C, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, Karnzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappa B and activator protein 1 in a redox-sensitive manner. J Vasc Res. 2005;42:415-423.
6. Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen deficient rats. Hypertension. 2005;46:76-81.
7. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R; Women's Health Intitiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med. 2006;166:357-365.
8. Reuben DB, Palla SL, Hu P, Reboussin BA, Crandall C, Herrington DM, Barrett-Connor E, Greendale GA. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation. Am J Med. 2006;119:167;e1-e8.
9. Vitale C, Cornoldi A, Gebara O, Silvestri A, Wajngarten M, Cerquetani E, Fini M, Ramires JA, Rosano GM. IL-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. Menopause. 2005;12:552-558.
10. Sumino H, Ichikawa S, Ohyama Y, Takahashi T, Saito Y, Nakamura T, Kanda T, Kurabayshi M. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. Am J Cardiol. 2005;96:148-153.
11. Alexander J, Clearfield M. Cardiovascular disease after menopause: a growing epidemic. Minerva Ginecol. 2006;58:35-60.